Testicular cancer diagnosis by non-invasive MRI
Friday, 26 February 2010- Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men...
Edited by: JV
Study suggests postchemotherapy RLND not necessary after complete remission
Tuesday, 29 December 2009- Patients obtaining a CR after first-line chemotherapy can be safely observed without PC-RPLND, according to a report published in the early online release of Journal of Clinical Oncology. It concludes...
Edited by: ES
Optimal management of patients with nonseminomatous germ cell tumour
Monday, 28 December 2009- Controversy arises regarding the optimal management of patients with nonseminomatous germ cell tumor (NSGCT) who achieve a serologic and radiographic complete remission (CR) to systemic chemotherapy....
Edited by: JV
Relatives of boys with hypospadias not at risk for testis cancer
Wednesday, 23 December 2009- Boys with the sexual birth defects known as hypospadias and cryptorchidism are at risk for developing testicular germ cell cancer, but their relatives are not, according to a new study published in...
Edited by: JV
Long-term testis cancer survivors experience more neurological side effects
Friday, 27 November 2009- Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy experience more severe side effects, including neurological side effects and Raynaud-like phenomena, than men...
Edited by: JV
QoL in long-term survivors of testicular cancer
Tuesday, 3 November 2009- A growing number of patients with testicular cancer (TC) become long-term survivors. As a consequence, quality-of-life (QOL) issues become increasingly important.
Rossen and colleagues investigated QOL...
Edited by: JV
Treatment not testis cancer is biggest risk to survivors' health
Monday, 19 October 2009- Survivors of testicular cancer face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a report published in the British...
Edited by: JV
Phase 2 trial of high-dose chemotherapy in patients with disseminated germ-cell tumours
Thursday, 2 July 2009- High-dose chemotherapy (HDCT) using the etoposide-carboplatin ± ifosfamide regimen is able to circumvent resistance in germ-cell tumour (GCT) patients (pts), even when used as third-line or later therapy...
Edited by: JV
BEP for CS1 non-seminoma: revising recommendations
Wednesday, 1 July 2009- In clinical stage I testicular cancer, one cycle of polychemotherapy (BEP) is as efficient as the currently accepted norm of two cycles of the same treatment, was one of the key messages at the 4th...
By Evgenia Starkova
Open versus laparoscopic RPLND in stage 1 nonseminomatous germ-cell tumours
Friday, 26 June 2009- Recurrence and complication rates in open and laparoscopic retroperitoneal lymph node dissection (RPLND) were examined by a group of Italian researchers. They presented their findings at the recent ASCO...
Edited by: JV
